Royalty Pharma Donates $1,000,000 To Support Mount Sinai’s COVID-19 Patient Care and Clinical Research

Royalty Pharma today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System.

Read more

Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

Read more

New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood

Read more

Mount Sinai study finds SARS-CoV-2 induces robust antibody responses stable for at least 3 months

Research from the Mount Sinai Health System, just posted to pre-print server MedRxiv (https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1), shows that the vast majority (more than

Read more

Mount Sinai seeks EUA from Food and Drug Administration for potential quantitative serologic test for COVID-19

If authorized for quantitative use, the assay could be used to provide a numeric result for the concentration of neutralizing anti-COVID-19 antibodies in plasma.

Read more

Mount Sinai Health System and Renalytix Form Joint Venture, Kantaro Biosciences, To Develop and Scale Production of COVID Antibody Test Kits

– Kantaro Biosciences partners with Bio-Techne for manufacturing and global kit distribution
– Scaled kit production to enable clinical laboratories to conduct 10M tests per month is planned to begin in July

Read more